News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
251,763 Results
Type
Article (34698)
Company Profile (14)
Press Release (217051)
Section
Business (76474)
Career Advice (1207)
Deals (10053)
Drug Delivery (12)
Drug Development (30439)
Employer Resources (65)
FDA (4957)
Job Trends (4472)
News (120946)
Policy (7865)
Tag
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Pharm Country Standard (1)
2026 Biotech Bay Standard (1)
Academia (2451)
Academic (1)
Accelerated approval (1)
Adcomms (8)
Allergies (35)
Alliances (15569)
ALS (30)
Alzheimer's disease (650)
Antibody-drug conjugate (ADC) (21)
Approvals (4988)
Artificial intelligence (66)
Autoimmune disease (1)
Automation (5)
Bankruptcy (34)
Best Places to Work (3761)
BIOSECURE Act (4)
Biosimilars (12)
Biotechnology (18)
Bladder cancer (19)
Brain cancer (11)
Breast cancer (93)
Cancer (665)
Cardiovascular disease (45)
Career advice (1008)
Career pathing (17)
CAR-T (43)
Cell therapy (134)
Cervical cancer (7)
Clinical research (24001)
Collaboration (217)
Compensation (29)
Complete response letters (3)
COVID-19 (1367)
CRISPR (11)
C-suite (142)
Cystic fibrosis (29)
Data (809)
Decentralized trials (1)
Denatured (3)
Depression (12)
Diabetes (66)
Diagnostics (2511)
Digital health (7)
Diversity (5)
Diversity, equity & inclusion (22)
Drug discovery (32)
Drug pricing (13)
Drug shortages (2)
Duchenne muscular dystrophy (24)
Earnings (22735)
Editorial (9)
Employer branding (6)
Employer resources (58)
Events (27386)
Executive appointments (432)
FDA (5293)
Featured Employer (4)
Frontotemporal dementia (4)
Funding (238)
Gene editing (31)
Generative AI (5)
Gene therapy (88)
GLP-1 (179)
Government (1422)
Grass and pollen (2)
Guidances (9)
Healthcare (7279)
Huntington's disease (4)
IgA nephropathy (5)
Immunology and inflammation (18)
Indications (11)
Infectious disease (1402)
Inflammatory bowel disease (53)
Inflation Reduction Act (1)
Influenza (18)
Intellectual property (21)
Interviews (267)
IPO (6281)
IRA (9)
Job creations (827)
Job search strategy (835)
Kidney cancer (5)
Labor market (8)
Layoffs (53)
Leadership (9)
Legal (1500)
Liver cancer (20)
Lung cancer (87)
Lymphoma (48)
Machine learning (1)
Management (20)
Manufacturing (56)
MASH (30)
Medical device (4650)
Medtech (4652)
Mergers & acquisitions (3957)
Metabolic disorders (157)
Multiple sclerosis (26)
NASH (5)
Neurodegenerative disease (26)
Neuropsychiatric disorders (2)
Neuroscience (805)
NextGen: Class of 2025 (2408)
Non-profit (2083)
Northern California (765)
Now hiring (4)
Obesity (59)
Opinion (60)
Ovarian cancer (32)
Pain (17)
Pancreatic cancer (26)
Parkinson's disease (38)
Partnered (7)
Patents (54)
Patient recruitment (36)
Peanut (22)
People (34750)
Pharmaceutical (3)
Pharmacy benefit managers (2)
Phase I (7192)
Phase II (10758)
Phase III (7842)
Pipeline (281)
Podcasts (5)
Policy (27)
Postmarket research (1191)
Preclinical (3565)
Press Release (26)
Prostate cancer (40)
Psychedelics (10)
Radiopharmaceuticals (106)
Rare diseases (111)
Real estate (1707)
Recruiting (28)
Regulatory (5505)
Reports (9)
Research institute (1459)
Resumes & cover letters (176)
Rett syndrome (1)
RNA editing (1)
RSV (1)
Schizophrenia (20)
Series A (33)
Series B (25)
Sickle cell disease (18)
Southern California (628)
Special edition (1)
Spinal muscular atrophy (51)
Sponsored (9)
Startups (1364)
Stomach cancer (1)
Supply chain (2)
The Weekly (1)
United States (6368)
Vaccines (255)
Venture capitalists (4)
Webinars (9)
Weight loss (34)
Women's health (8)
Worklife (6)
Date
Today (67)
Last 7 days (200)
Last 30 days (830)
Last 365 days (10933)
2025 (2578)
2024 (11312)
2023 (13623)
2022 (18653)
2021 (21839)
2020 (21155)
2019 (18046)
2018 (13208)
2017 (12883)
2016 (12140)
2015 (15018)
2014 (11052)
2013 (10200)
2012 (10493)
2011 (10794)
2010 (9371)
Location
Africa (398)
Alabama (11)
Alaska (3)
Arizona (55)
Arkansas (6)
Asia (18865)
Australia (3494)
California (1626)
Canada (633)
China (117)
Colorado (69)
Connecticut (76)
Delaware (39)
Europe (42961)
Florida (256)
Georgia (63)
Idaho (15)
Illinois (179)
India (4)
Indiana (97)
Iowa (2)
Japan (53)
Kansas (17)
Kentucky (4)
Maine (46)
Maryland (217)
Massachusetts (1083)
Michigan (52)
Minnesota (118)
Mississippi (1)
Missouri (21)
Montana (6)
Nebraska (4)
Nevada (16)
New Hampshire (14)
New Jersey (527)
New Mexico (9)
New York (547)
North Carolina (350)
North Dakota (2)
Northern California (765)
Ohio (73)
Oklahoma (6)
Oregon (9)
Pennsylvania (381)
Puerto Rico (1)
Rhode Island (11)
South America (486)
South Carolina (4)
Southern California (628)
Tennessee (29)
Texas (225)
Utah (48)
Virginia (53)
Washington D.C. (17)
Washington State (148)
West Virginia (1)
Wisconsin (14)
251,763 Results for "tel aviv university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biomed 2024, Israel’s Leading Annual Life Science Conference and Exhibition, May 21-23, in Tel Aviv
Biomed Israel , the premier international Life Science and HealthTech conference in Israel , will take place on May 21-23, 2024 , at the David InterContinental Hotel in Tel Aviv, Israel.
April 18, 2024
·
3 min read
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
Axogen, Inc. announces the launch of its newest product, Avive+ Soft Tissue Matrix™. Avive+™ is intended for use as a soft tissue barrier and is a resorbable, multi-layer amniotic membrane allograft that provides temporary protection and tissue separation during the critical phase of peripheral nerve healing.
June 24, 2024
·
6 min read
Genetown
Tel Aviv Sourasky Medical Center Chooses SOPHiA DDMTM HRD Solution of SOPHiA GENETICS
SOPHiA DDMTM HRD Solution will help empower clinical researchers to advance cancer research SOPHiA GENETICS, a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced that Tel Aviv Sourasky Medical Center, the largest acute care facility in Israel, has chosen to use SOPHiA DDM™ to enhance its genetic testing capabilities.
April 4, 2023
·
4 min read
Policy
Protalix BioTherapeutics to Delist its Common Stock from the Tel Aviv Stock Exchange
Protalix BioTherapeutics, Inc. announced that the Company’s management and Board of Directors have decided that it is in the best interest of the Company to voluntarily delist its common stock from the Tel Aviv Stock Exchange.
December 21, 2022
·
5 min read
Inspira™ Technologies to Present Advanced Respiratory Solutions to Key International Leaders at the Annual iECOs Conference in Tel Aviv, Israel
Inspira™ Technologies announced today that the company will present at the annual iECOs Conference in Tel Aviv, Israel on November 10th, 2022.
November 8, 2022
·
3 min read
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the first surgical implantations of its newest product, Avive+ Soft Tissue Matrix™.
April 29, 2024
·
5 min read
Policy
BiomX Announces Voluntary Delisting from the Tel Aviv Stock Exchange
BiomX Inc., a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announced that it is voluntarily delisting its shares of common stock from trading on the Tel Aviv Stock Exchange.
July 6, 2022
·
3 min read
Positive Data from IceCure’s Kidney Cancer Clinical Study Presented at Interventional Radiology Conference: Minimally Invasive Approach Results in Shorter Hospitalization and Minor Impact on Renal Function
IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure”, “IceCure Medical” or the “Company”) today announced that data from an interim analysis of its ICESECRET kidney cancer trial were presented at the 3rd Annual Israeli Conference on Interventional Radiology in Tel Aviv, Israel on June 10, 2024.
June 12, 2024
·
5 min read
BioMidwest
Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week
Veru Inc. announced that Mitchell Steiner, M.D., Chairman, President, and Chief Executive Officer, will be a Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology Week, taking place May 21-23, 2024, in Tel Aviv, Israel.
May 14, 2024
·
10 min read
Aviv Clinics Highlights Case Report Showing Hyperbaric Oxygen Therapy Improves Post-Stroke Rehabilitation, Specifically Hand Motor Recovery
Aviv Clinics, one of the world’s most advanced brain clinics, shares the results of a new case report showing a unique hyperbaric oxygen therapy (HBOT) protocol was effective for improving hand motor function in a chronic post-stroke patient.
October 2, 2023
·
4 min read
1 of 25,177
Next